Sanofi/Bristol Plavix Patent Suit To Begin Against Apotex
This article was originally published in The Pink Sheet Daily
Executive Summary
With preliminary injunction rulings weighing in Sanofi/Bristol's favor, Apotex's defense will need to make a strong case that clopidogrel patents are invalid.